New Student User- Use Code HELLO

Register Now

Pfizer acquires Seagen for cancer treatment development

Published on March 14, 2023
Current context: Pfizer will spend 43 billion dollar to buy Seagen for cancer research development. Pfizer will pay 229 dollar per share to Seagen.
Pfizer acquires Seagen for cancer treatment development
  • Both the companies will collaborate to provide Seagen’s antibody drug conjugate (ADC) with the help of Pfizer’s expertise in the field.
  • Seagen is a Washington based company which is a biotech drug developer. It mainly specializes in cancer treatment.
  • Seagen’s top seller, Adcertis, also made a deal with Pfizer’s Array BioPharma to treat breast cancer.
  • Pfizer is a New York based company, has also contributed 11.6 billion dollars to migraine treatment developer Biohaven Pharmaceuticals.
  • Pfizer concludes that Seagen can provide more than 10 billion dollars revenue until 2030 in the field of cancer treatment.


Q.1 Pfizer has collaborated with_______ for cancer treatment development.
c. Seagen
d. IIT Kanpur
ebook store

About us

ramandeep singh

Ramandeep Singh is a seasoned educator and banking exam expert at BankExamsToday. With a passion for simplifying complex concepts, he has been instrumental in helping numerous aspirants achieve their banking career goals. His expertise and dedication make him a trusted guide in the journey to banking success.

  • Follow me:
Close Menu
Close Menu